http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7467006-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47d4d79debde953afe2bc27b1c16c037
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-5601
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B6-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01V3-00
filingDate 2004-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2008-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce6c3884888ec057ebd34938dfd562d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ba222eae07a86a2645998d23c54cf6a
publicationDate 2008-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-7467006-B2
titleOfInvention Magnetic resonance imaging system and contrast-enhanced angiography
abstract An MRI system capable of acquiring a high-quality blood vessel image even during a measuring period other than at an injected contrast medium concentration peak by always picking up an image under optimum conditions while following up with an injected contrast medium concentration that changes every moment in the body. A flip angle is changed according to a contrast medium concentration b(t) as shown by a curve ( 102 ). During a period (Da) where a contrast medium concentration b(t) gradually increases, a flip angle (FA) increases according to a contrast medium concentration b(t); and during a period (Db) where a contrast medium concentration b(t) gradually decrease, a flip angle is gradually decreased. If a flip angle is controlled so as to follow up with a contrast medium concentration b(t) and reach an Ernst's angle at which a single intensity is at a maximum, a high-quality blood vessel image can be acquired even during a measuring period other than at an injected contrast medium concentration peak.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013066198-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7787684-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015150526-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007036413-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10159454-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9483824-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9433392-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015161788-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004092813-A1
priorityDate 2003-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0072032-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001276016-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001212108-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5553619-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6381486-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450540594

Total number of triples: 32.